Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association ofGPX1polymorphism and recurrent Hurthle cell thyroid carcinoma [PDF]
Blaž Krhin +4 more
openalex +1 more source
ABSTRACT Background Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high‐risk thyroid surgeries. Methods Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005–2024).
Anastasios Maniakas +19 more
wiley +1 more source
Oncocytic Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Case Report. [PDF]
Joseph KA, Ahuja S, Zaheer S.
europepmc +1 more source
What you see might not be what you get: Analysis of 15 prospective cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). [PDF]
Al Hassan MS +4 more
europepmc +1 more source
Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies [PDF]
Derfuss, Tobias +4 more
core +1 more source
Exploring Transitions in Care Among Patients With Head and Neck Cancer: A Scoping Review
ABSTRACT Background Individuals living with and beyond head and neck cancer (HNC) experience many transitions in care (TiC), as their treatment and care involve a team of multidisciplinary healthcare providers across a variety of settings. TiC can be associated with medical error, patient dissatisfaction with care, and overuse of healthcare resources ...
L. Fillo +9 more
wiley +1 more source
Diagnosis of Thyroid Neoplasm-Associated Dermatomyositis in Ethiopian Woman. [PDF]
Legese GL +6 more
europepmc +1 more source
Horizontal Lateral Thyroidectomy - “Thomas Technique” A Novel Surgical Approach to Thyroid Neoplasms
Thomas Varughese
openalex +1 more source
ABSTRACT Objective To compare functional and oncologic outcomes in elderly (≥ 70 years) and nonelderly (< 70 years) patients after transoral robotic surgery (TORS). Methods A retrospective chart review was conducted on 114 patients who underwent TORS for head and neck squamous cell carcinoma between 2012 and 2022.
Erim Pamuk +6 more
wiley +1 more source

